Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6506
    +0.0006 (+0.09%)
     
  • OIL

    82.66
    -0.15 (-0.18%)
     
  • GOLD

    2,332.00
    -6.40 (-0.27%)
     
  • Bitcoin AUD

    98,910.02
    -3,922.64 (-3.81%)
     
  • CMC Crypto 200

    1,395.29
    -28.81 (-2.02%)
     
  • AUD/EUR

    0.6073
    +0.0003 (+0.04%)
     
  • AUD/NZD

    1.0948
    +0.0006 (+0.06%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,088.70
    -48.95 (-0.27%)
     
  • Hang Seng

    17,124.35
    -76.92 (-0.45%)
     
  • NIKKEI 225

    37,939.83
    -520.25 (-1.35%)
     

Insider Buying: The SciDev Limited (ASX:SDV) Non-Executive Chairman Just Bought 8.7% More Shares

Whilst it may not be a huge deal, we thought it was good to see that the SciDev Limited (ASX:SDV) Non-Executive Chairman, Trevor Jones, recently bought AU$62k worth of stock, for AU$0.65 per share. However, it only increased their shares held by 8.7%, and it wasn't a huge purchase by absolute value, either.

View our latest analysis for SciDev

SciDev Insider Transactions Over The Last Year

In fact, the recent purchase by Trevor Jones was the biggest purchase of SciDev shares made by an insider individual in the last twelve months, according to our records. So it's clear an insider wanted to buy, at around the current price, which is AU$0.67. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today's share price, as the discount to value may have narrowed with the rising price. Happily, the SciDev insiders decided to buy shares at close to current prices.

ADVERTISEMENT

In the last twelve months SciDev insiders were buying shares, but not selling. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does SciDev Boast High Insider Ownership?

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. SciDev insiders own about AU$17m worth of shares. That equates to 17% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

What Might The Insider Transactions At SciDev Tell Us?

The recent insider purchases are heartening. And an analysis of the transactions over the last year also gives us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. When combined with notable insider ownership, these factors suggest SciDev insiders are well aligned, and that they may think the share price is too low. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 4 warning signs for SciDev you should be aware of, and 1 of them is a bit unpleasant.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.